Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial

Autor: Shitara, Kohei, Doi, Toshihiko, Dvorkin, Mikhail, Mansoor, Wasat, Arkenau, Hendrik-Tobias, Prokharau, Aliaksandr, Alsina, Maria, Ghidini, Michele, Faustino, Catia, Gorbunova, Vera, Zhavrid, Edvard, Nishikawa, Kazuhiro, Hosokawa, Ayumu, Yalçın, Şuayib, Fujitani, Kazumasa, Beretta, Giordano D, Cutsem, Eric Van, Winkler, Robert E, Makris, Lukas, Ilson, David H, Tabernero, Josep
Zdroj: In The Lancet Oncology November 2018 19(11):1437-1448
Databáze: ScienceDirect